Lisa Koff is counsel in the Corporate Department and a member of the firm’s Private Funds Group. Her practice focuses on advising private equity fund clients on matters relating to fund formation, operations, compliance and portfolio investing activities.
Ms. Koff also has considerable experience representing clients in transactional matters, including joint ventures, public and private securities offerings and mergers and acquisitions. In addition, she spent six years (from 1994-2000) between law firm practice as Vice President and General Counsel of Synaptic Pharmaceutical Corporation, a publicly traded biotechnology company. While there, she was responsible for all of the company’s transactional work, including the company’s initial and subsequent public offerings, technology transfers and research collaborations, as well as securities compliance, intellectual property estate management, and employment matters.
Most recently, Lisa was recognized by The Legal 500 for her work in Investment Fund Formation & Management: Private Equity Funds.